<DOC>
	<DOCNO>NCT01363609</DOCNO>
	<brief_summary>The aim study investigate endogenous Glucagon Like Peptide -1 ( GLP-1 ) effect brain satiety reward system alteration obese patient type 2 diabetes ( T2DM ) . Secondly , aim investigate whether treatment GLP-1 analog , liraglutide , restore signal obese patient type 2 diabetes . Finally , also endogenous GLP-1 effect investigate obese individual gastric bypass surgery brain satiety reward system .</brief_summary>
	<brief_title>Effects Glucagon Like Peptide-1 ( GLP-1 ) Liraglutide Brain Satiety Reward Circuits Feeding Behavior Diabetes</brief_title>
	<detailed_description>First aim address cross-sectional randomized study . 20 healthy , lean 20 obese individual type 2 diabetes ( T2DM ) expose food cue concomitant infusion glucagon Like peptide-1 ( GLP-1 ) receptor antagonist saline , assess involvement endogenous GLP-1 , secrete response meal . Measurements activation CNS circuit involve satiety reward perform use blood oxygen level-dependent ( BOLD ) functional magnetic resonance imaging ( fMRI ) . The second aim address cross-over randomized-controlled trial ( RCT ) T2DM patient . Patients randomly assign liraglutide vs insulin glargine treatment , treatment period 12 week 12-week washout period . The investigator perform fMRI protocol . The third aim address study obese individual schedule gastric bypass surgery . The protocol first aim perform surgery individual .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>For healthy , lean individual : Age 1865 year Women : post menopausal ( exclude possible menstruation cycle effect ) Bodymass index ( BMI ) &lt; 25 kg/m2 , Stable bodyweight ( &lt; 5 % report change previous 3 month ) . Normal fast 2h post load glucose ascertain 75g oral glucose tolerance test ( OGTT ) ( 34 ) Right hand For obese T2DM individual : Age 1865 year Women : post menopausal ( exclude possible menstruation cycle effect ) BMI 2540 kg/m2 Stable bodyweight ( &lt; 5 % report change previous 3 month ) . Diagnosed T2DM &gt; 3 month prior screen HbA1C 6.58.5 % Treatment metformin stable dose least 3 month . Right hand For obese individual schedule gastric bypass surgery : Age 1865 year Women : preferably post menopausal ( exclude possible menstruation cycle effect ) Bodymass index ( BMI ) &gt; 30 kg/m2 , Stable bodyweight ( &lt; 5 % report change previous 1 month ) . Normal impaired fast 2h post load glucose ascertain 75g oral glucose tolerance test ( OGTT ) ( define glucose fast &lt; 7.1 mmol/l OGTT t=120min &lt; 11.0 mmol/l ) ( 39 ) Right hand GLP1 base therapy , thiazolidinediones , sulphonylurea insulin within 3 month screen Weightlowering agent within 3 month screen . Congestive heart failure ( NYHA IIIV ) Chronic renal failure ( glomerular filtration rate &lt; 60 mL/min/1.73m2 per Modification Diet Renal Disease ( MDRD ) ) Liver disease History gastrointestinal disorder ( include gastropareses , pancreatitis cholelithiasis ) Neurological illness Malignancy Other type bariatric surgery ( RedoGBP , sleeve , distal GBP , adj banding , Scopinaro ) History major heart disease History major renal disease Pregnancy breast feed Implantable device Substance abuse Addiction Contraindication MRI , claustrophobia pacemaker Any psychiatric illness ; include eat disorder depression Chronic use centrally act agent glucocorticoid within 2 week immediately prior screening . Use cytostatic immune modulatory agent History know allergy acetaminophen . History allergy insulin analog History allergy liraglutide Participation study Individuals receive treatment within last 30 day drug receive regulatory approval indication time study entry Individuals investigator site personnel , directly affiliate study , immediate family</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>